rs201236317
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_032119.4(ADGRV1):c.1033C>A(p.Gln345Lys) variant causes a missense change. The variant allele was found at a frequency of 0.000625 in 1,613,694 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_032119.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000717 AC: 109AN: 152114Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000855 AC: 213AN: 249052Hom.: 0 AF XY: 0.000792 AC XY: 107AN XY: 135100
GnomAD4 exome AF: 0.000615 AC: 899AN: 1461580Hom.: 2 Cov.: 32 AF XY: 0.000620 AC XY: 451AN XY: 727076
GnomAD4 genome AF: 0.000717 AC: 109AN: 152114Hom.: 0 Cov.: 32 AF XY: 0.000929 AC XY: 69AN XY: 74292
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:4
- -
- -
- -
- -
- -
not specified Benign:1
p.Gln345Lys in exon 7 of GPR98: This variant is not expected to have clinical si gnificance because it has been identified in 0.2% (135/66722) of European chromo somes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs201236317), and the glutamine (Gln) residue at position 345 is not evol utionarily conserved across species, with many species having a lysine (Lys) at this position. -
ADGRV1-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at